Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
336.36
-3.04 (-0.90%)
At close: Oct 29, 2025, 4:00 PM EDT
338.00
+1.64 (0.49%)
After-hours: Oct 29, 2025, 7:28 PM EDT
Elevance Health Market Cap
Elevance Health has a market cap or net worth of $74.75 billion as of October 29, 2025. Its market cap has decreased by -35.77% in one year.
Market Cap
74.75B
Enterprise Value
98.64B
1-Year Change
-35.77%
Ranking
Category
Stock Price
$336.36
Market Cap Chart
Since October 30, 2001, Elevance Health's market cap has increased from $4.17B to $74.75B, an increase of 1,694.56%. That is a compound annual growth rate of 12.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 75.43B | -11.84% |
| Dec 31, 2024 | 85.56B | -22.78% |
| Dec 29, 2023 | 110.80B | -9.56% |
| Dec 30, 2022 | 122.51B | 8.89% |
| Dec 31, 2021 | 112.51B | 40.89% |
| Dec 31, 2020 | 79.86B | 4.27% |
| Dec 31, 2019 | 76.58B | 12.74% |
| Dec 31, 2018 | 67.93B | 17.57% |
| Dec 29, 2017 | 57.77B | 52.54% |
| Dec 30, 2016 | 37.87B | 4.04% |
| Dec 31, 2015 | 36.40B | 7.31% |
| Dec 31, 2014 | 33.92B | 24.29% |
| Dec 31, 2013 | 27.29B | 47.54% |
| Dec 31, 2012 | 18.50B | -19.73% |
| Dec 30, 2011 | 23.05B | 2.97% |
| Dec 31, 2010 | 22.38B | -16.23% |
| Dec 31, 2009 | 26.72B | 24.58% |
| Dec 31, 2008 | 21.45B | -57.21% |
| Dec 31, 2007 | 50.12B | 2.73% |
| Dec 29, 2006 | 48.79B | -0.77% |
| Dec 30, 2005 | 49.17B | 208.05% |
| Dec 31, 2004 | 15.96B | 53.90% |
| Dec 31, 2003 | 10.37B | 16.57% |
| Dec 31, 2002 | 8.90B | 74.35% |
| Dec 31, 2001 | 5.10B | 22.50% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |